Editorial

groupview

Abstract
Pharmacognosy Communications,2019,9,4,123.
Published:September 2019
Type:Editorial

Editorial

Ian Edwin Cock1,2,*

1Environmental Futures Research Institute, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.

2School of Natural Sciences, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.

Abstract:

Dear Readers and Authors,

I am pleased to bring you Volume 9, Issue 4 of Pharmacognosy Communications. In this issue we present new research reports examining the pharmacognosy of several important medicinal plants including two studies examining the antibacterial activity of the endemic Australian plant Tasmannia lanceolata (Poir.) A.C.Sm. against Yersinia enterolitica and Bacillus anthracis. A further study reports the hematopoietic effects of Amaranthus cruentus L. extract on cyclophosphamide induced toxicity in rats. We also include a study reporting the isolation of the ellagitannin corilagen from Phyllanthus maderaspatensis L. for the first time. The final study included in this issue reports that Cordyline rubra Otto and A. Dietr. leaf and fruit lack antibacterial activity against a panel of human pathogens. Whilst this study reports negative results, it is important that these be published to decrease redundancy in testing between different research groups. Read more. . . 

Keywords:Nil
Tags: 

Cite This Article

Vancouver Style :: Cock IEdwin. Editorial. Pharmacognosy Communications. 2019;9(4):123.  (232.81 KB)
MLA Style: Cock IEdwin. Editorial. Pharmacognosy Communications. 2019;9(4):123.  (232.81 KB)
CSE Style: Cock IEdwin. Editorial. Pharmacognosy Communications. 2019;9(4):123.  (232.81 KB)
APA Style: Cock IEdwin. Editorial. Pharmacognosy Communications. 2019;9(4):123.  (232.81 KB)

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.